• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO S. DE R.L. DE CV NC EUPHORA RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO S. DE R.L. DE CV NC EUPHORA RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, Back to Search Results
Model Number NCEUP3020X
Medical Device Problem Code Deflation Problem (1149)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/05/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that during a procedure involving one nc euphora balloon catheter deflation difficulties were encountered.The balloon was very slow to deflate at the lesion site.The device was inspected prior to use and negative prep was performed with no issues.The lesion was pre-dilated.The device did pass through a previously deployed stent.Resistance was not encountered when advancing the device.Excessive force was not used during delivery.No patient complications have been reported as a result of this event.
 
Additional Manufacturer Narrative
Additional information: it was not difficult to remove the protective sheath or the packaging stylette.There were no difficulties noted during inflations of the device.It was detailed that the balloon was successfully inflated four times without issue.However, after the fifth inflation, deflation was extremely slow.The balloon eventually fully deflated.The device was not moved or repositioned while inflated.A 50/50 concentration of contrast/saline was used.No intervention was required to remove the device from the patient.There was no injury to the patient as a result of the event.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Additional information: lot number provided.Annex d code updated.Product analysis: the device returned for evaluation.A 0.014" guidewire was loaded into the returned device.The balloon was inflated to its nominal pressure of 12atms.The balloon was deflated, and it took approximately 2 minutes to deflate the balloon.The balloon was then inflated to its rated burst pressure (rbp) of 20atms.The balloon was deflated, and it took approximately 2 minutes to deflate the balloon.Deflation time from rbp specification: = 20 seconds a visual inspection could find no issues with the inflation/deflation lumen or with the rest of the device.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EUPHORA RX
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY,
Manufacturer (Section D)
MEDTRONIC MEXICO S. DE R.L. DE CV
av. paseo cucapah 10510 el lag
tijuana baja california,mx 22570
MX  22570
Manufacturer (Section G)
MEDTRONIC MEXICO S. DE R.L. DE CV
av. paseo cucapah 10510 el lag
tijuana baja california,mx 22570
MX   22570
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key22296859
Report Number9612164-2025-03057
Device Sequence Number8921852
Product Code LOX
UDI-Device Identifier00643169395848
UDI-Public(01)00643169395848(17)270206(10)230624147
Combination Product (Y/N)N
Initial Reporter StateHI
Initial Reporter CountryUS
PMA/510(K) Number
K141090
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/09/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberNCEUP3020X
Device Catalogue NumberNCEUP3020X
Device Lot Number230624147
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/06/2025
Supplement Date Received by Manufacturer06/21/2025
08/27/2025
Initial Report FDA Received Date06/20/2025
Supplement Report FDA Received Date07/02/2025
09/09/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/06/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-